The Impact of Strong Inducers on Direct Oral Anticoagulant Levels-Reference-Cited by-同舟云学术

The Impact of Strong Inducers on Direct Oral Anticoagulant Levels

Published:2021-10 Issue:10 Volume:134 Page:1295-1299
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Sennesael Anne-Laure^ORCID,Larock Anne-Sophie,Hainaut Philippe,Lessire Sarah,Hardy Michael^ORCID,Douxfils Jonathan^ORCID,Spinewine Anne,Mullier François

Publisher

Elsevier BV

Subject

General Medicine

Reference12 articles.

1. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism;Ortel;Blood Adv,2020

3. Laboratory monitoring of non-vitamin K antagonist oral anticoagulant use in patients with atrial fibrillation: a review;Eikelboom;JAMA Cardiol,2017

4. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants;Testa;J Thromb Haemost,2018

5. The P-glycoprotein transport system and cardiovascular drugs;Wessler;J Am Coll Cardiol,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events;JAMA Neurology;2024-08-01

2. Convulsive status epilepticus and its early treatment;Neurologie pro praxi;2024-06-20

3. Interactions between antiepileptic drugs and direct oral anticoagulants for primary and secondary stroke prevention;Expert Opinion on Drug Metabolism & Toxicology;2024-05-03

4. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study;Blood Advances;2024-04-10

5. LOW LEVELS OF DIRECT ORAL ANTICOAGULANTS AT STEADY STATE IN ATRIAL FIBRILLATION PATIENTS WHO LATER DEVELOP THROMBOTIC COMPLICATIONS; THE PROSPECTIVE MAS (MEASURE AND SEE) STUDY;2023-12-10